United Kingdom· GB-APID-8075411000001103
Visipaque 270 solution for injection 20ml bottles
A iodixanol product containing iodixanol, registered in United Kingdom by Amersham Health. The same ATC class is registered in 16 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Iodixanol is registered in 16 of 19 countries.
Countries holding a registration under ATC V08AB09 (iodixanol), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Iodixanol · ATC V08AB09
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Iodixanol
- Manufacturer
- Amersham Health
- Country
- United Kingdom (GB)
- ATC code
- V08AB09
- ATC class
- Iodixanol
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
172 interactions on record for iodixanol.
Graded by severity as the source publishes them — 87 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iodixanol · interactions on record
172 records
- 87 severe
- 50 moderate
- 35 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Amphotericin BA07AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Iodixanol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVisipaque 270 mg I/mlGE Healthcare
- IrelandVISIPAQUE 270 mg I/ml Solution for Injection, glass containerGE Healthcare AS
- NorwayVisipaqueGE Healthcare AS
- SwedenVisipaque 270 mg I/ml Injektionsvätska, lösningGE Healthcare AS
- CzechiaVISIPAQUEGE Healthcare AS, Oslo
- United StatesIodixanolFRESENIUS KABI USA, LLC
- GermanyVisipaqueGe Healthcare Buchler Gmbh & Co. Kg
- FinlandVisipaqueGE Healthcare AS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Visipaque
- Belgium · Visipaque
- Bulgaria · Визипак
- Cyprus · Visipaque
- Czechia · Visipaque
- Germany · Visipaque
- Denmark · Visipaque
- Estonia · Visipaque
- Spain · Visipaque
- Finland · Visipaque
- France · Visipaque
- Greece · Visipaque
- Croatia · Visipaque
- Hungary · Visipaque
- Ireland · Visipaque Glass Container, Visipaque Polypropylene Container
- Iceland · Visipaque
- Italy · Visipaque
- Lithuania · Visipaque
- Luxembourg · Visipaque
- Latvia · Visipaque
- Malta · Visipaque
- Netherlands · Visipaque
- Norway · Visipaque
- Poland · Visipaque
- Portugal · Visipaque
- Romania · Visipaque
- Sweden · Visipaque
- Slovenia · Visipaque
- Slovakia · Visipaque
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfce017e-fa73-4a97-b50e-362a9967e95b GET /v1/drugs/cfce017e-fa73-4a97-b50e-362a9967e95b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "8075411000001103",
"desc": "Visipaque 270 solution for injection 20ml bottles (Amersham Health)",
"form": "Solution for injection",
"vpid": "8072411000001106",
"source": "dmd",
"vtm_id": "776370003",
"strength": "270 mg",
"substance": "Iodixanol",
"ingredient": "Iodixanol",
"supplier_code": "6131711000001107"
}See everything about iodixanol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.